The Heyday of Biotech Dealmaking

Deal values and perks are up for biotechs; the Pharmaceutical Strategic Outlook conference suggests Big Pharma might begin to borrow some biotech strategies.

Melanie Senior

If only the stock market would cooperate, life would be pretty good for biotech.

More from Business Strategy

More from In Vivo